ALGN vs. BMY: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and BMY, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
BMY stands out with 95.18 billion USD in market value—about 7.64× ALGN’s market cap of 12.46 billion USD.
ALGN’s beta of 1.68 points to much larger expected swings compared to BMY’s calmer 0.40, suggesting both higher upside and downside potential.
| Symbol | ALGN | BMY |
|---|---|---|
| Company Name | Align Technology, Inc. | Bristol-Myers Squibb Company |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Drug Manufacturers - General |
| CEO | Mr. Joseph M. Hogan | Dr. Christopher S. Boerner Ph.D. |
| Price | 171.91 USD | 46.77 USD |
| Market Cap | 12.46 billion USD | 95.18 billion USD |
| Beta | 1.68 | 0.40 |
| Exchange | NASDAQ | NYSE |
| IPO Date | January 30, 2001 | June 1, 1972 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and BMY over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ALGN and BMY based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- BMY shows a negative forward PEG of -3.01, signaling expected earnings contraction, while ALGN at 2.92 maintains analysts’ projections for stable or improved profits.
| Symbol | ALGN | BMY |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 30.88 | 17.53 |
| Forward PEG Ratio (TTM) | 2.92 | -3.01 |
| Price-to-Sales Ratio (P/S, TTM) | 3.13 | 2.00 |
| Price-to-Book Ratio (P/B, TTM) | 3.33 | 5.46 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 19.76 | 7.27 |
| EV-to-EBITDA (TTM) | 14.56 | 8.38 |
| EV-to-Sales (TTM) | 2.94 | 2.85 |
| EV-to-Free Cash Flow (TTM) | 18.56 | 10.36 |
Dividend Comparison
ALGN offers a 0% dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while BMY provides a 5.22% dividend yield, giving investors a steady income stream.
| Symbol | ALGN | BMY |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 5.22% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALGN and BMY, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ALGN shows “--” for interest coverage, hinting at negligible interest costs, whereas BMY (at 4.36) covers its interest obligations.
| Symbol | ALGN | BMY |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 1.28 |
| Quick Ratio (TTM) | 1.08 | 1.17 |
| Debt-to-Equity Ratio (TTM) | 0.03 | 2.95 |
| Debt-to-Assets Ratio (TTM) | 0.02 | 0.55 |
| Interest Coverage Ratio (TTM) | -- | 4.36 |